<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002111050</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <dateOfEvent>06/22/2026</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001326706</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>29416M103</issuerCusipNumber>
        </issuerCusips>
        <issuerName>ENvue Medical, Inc.</issuerName>
        <address>
          <com:street1>969 PRUITT AVE,</com:street1>
          <com:city>TYLER</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>77569</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Christian Glibert</personName>
          <personPhoneNum>7405077228</personPhoneNum>
          <personAddress>
            <com:street1>4001 GREEN HERON SPRING DR</com:street1>
            <com:city>Carpinteria</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>93013</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002111050</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Glibert Christian Michael</reportingPersonName>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>0.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.0</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock</securityTitle>
        <issuerName>ENvue Medical, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>969 PRUITT AVE,</com:street1>
          <com:city>TYLER</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>77569</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>This Amendment No. 2 is being filed by Christian Michael Glibert. The citizenship, principal occupation, and background of the Reporting Person have not changed since the filing of the initial Schedule 13D</filingPersonName>
      </item2>
      <item3>
        <fundsSource>Item 3 is hereby amended and supplemented by adding the following:
Not applicable. The transactions reported herein involve the disposition (sale) of securities of the Issuer, and no funds were expended by the Reporting Person</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Item 4 is hereby amended and supplemented by adding the following:
This Amendment No. 2 is being filed to report that the Reporting Person has fully liquidated his investment position in the Issuer. On June 22, 2026, the Reporting Person disposed of all remaining shares of Common Stock of the Issuer held by him. Except as a result of the transactions described in Item 5, the Reporting Person has no current plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Item 5 is hereby amended and restated in its entirety as follows:

(a) As of June 22, 2026, the Reporting Person beneficially owns 0 shares of Common Stock of the Issuer, representing 0.0% of the outstanding shares.






</percentageOfClassSecurities>
        <numberOfShares>(b) The Reporting Person has sole voting power and sole dispositive power over 0 shares of Common Stock, and shared voting power and shared dispositive power over 0 shares of Common Stock.</numberOfShares>
        <transactionDesc>(c) On June 22, 2026, the Reporting Person disposed of an aggregate of 210,000 shares of Common Stock in open market transactions at a weighted average price of $0.6880 per share. The shares were sold in multiple tranches at prices ranging from $0.6756 to $0.7220.
</transactionDesc>
        <listOfShareholders>(d) Not applicable.</listOfShareholders>
        <date5PercentOwnership>(e) On June 22, 2026, the Reporting Person ceased to be the beneficial owner of more than 5.0% of the Common Stock of the Issuer.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Item 6 is hereby amended and supplemented by adding the following:
The information set forth in Item 4 and Item 5 of this Amendment No. 2 is incorporated herein by reference. There are no contract arrangements, understandings, or relationships between the Reporting Person and any other person with respect to the securities of the Issuer.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>None</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Glibert Christian Michael</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Christian Michael Glibert</signature>
          <title>Christian Michael Glibert</title>
          <date>06/22/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
